Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

EME, GVA, ST, PWRM - Stock Reports! from




EMCOR Group, Inc. (NYSE:EME) announced that, as previously reported during its November Third Quarter 2010 Earnings Call, its EMCOR Services Scalise Industries subsidiary has been awarded a contract for the installation of the mechanical, electrical and plumbing systems for an expansion project at Wheeling Hospital in Wheeling, West Virginia.

EMCOR Group, Inc. is an electrical and mechanical construction and facilities services company. It has six segments: United States electrical construction and facilities services, which involves systems for electrical power transmission and distribution.


Granite Construction Inc. (NYSE:GVA) announced that Eastside Corridor Constructors (NYSE:ECC), a joint venture team comprising Granite Construction Company and PCL Construction Services, Inc., has been awarded a $306 million contract by the Washington Department of Transportation (WSDOT) to reconstruct and widen the existing State Route 520 in King County.

Granite Construction Incorporated (Granite) is a heavy civil construction contractor in the United States. The Company operates nationwide, serving both public and private sector clients. Within the public sector, it primarily concentrate on heavy-civil infrastructure projects.


Power3 Medical Products, Inc. (OTC:PWRM)

PWRM was founded in 1992 and is based in The Woodlands, Texas. PWRM, a bio-technology company, engages in the development and marketing of diagnostic tests in the fields of cancer, and neurodegenerative and neuromuscular diseases in the United States. PWRM’s products include BC-SeraPro, a proteomic blood serum test for the early detection of breast cancer; and NuroPro, a serum test for the detection of neurodegenerative diseases, such as amyotrophic lateral sclerosis, Alzheimer’s disease, and Parkinson’s disease. PWRM’s products analyze proteins and their mutations to assess an individual’s risk for developing disease later in life or a patient’s likelihood of responding to a particular drug; assess a patient’s risk of disease progression and disease recurrence; and measure a patient’s exposure to drug therapy. PWRM was formerly known as Surgical Safety Products, Inc. and changed its name to Power3 Medical Products, Inc. in September 2003.

Breast cancers is undoubtedly an unchecked development of malignant breast cells. Melanoma develops due to the strains, as well as unusual changes, inside the genes responsible for controlling the growth of cells along with keeping all of them in good health. The genes are usually in each and every cells' nucleus, which usually function as the control room of each cell. Normally, the cells within our bodies replace themselves through an organized procedure for cell expansion: healthy completely new cells take over as old ones die away. However over time, cancerous strains can "turn on" certain genes and "turn off" others in a cell. That transformed cell gets the cabability to continue dividing without control or order, developing extra cells as well as developing a cancerous growth.

To learn more about PWRM visit:


Sensata Technologies Holding N.V. (NYSE:ST) announced earlier this month that the underwriters exercised their over-allotment option to purchase an additional 3,000,000 ordinary shares from the selling shareholders participating in Sensata Technologies' previously announced secondary offering at a price to the public of $24.10 per share.

Sensata Technologies Holding N.V. (Sensata) is a global industrial technology company engaged in the development, manufacture and sale of sensors and controls. The Company produces a range of customized sensors and controls for applications.



Signup for FREE Daily Stock Alerts From


Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.  Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).